Cancer

Rydapt approved for adults with acute myeloid leukemia

(HealthDay)—Rydapt (midostaurin) has been approved by the U.S. Food and Drug Administration, in combination with chemotherapy, to treat adults with acute myeloid leukemia (AML) who have a specific genetic mutation dubbed ...

Apr 28, 2017
popularity0 comments 0
  • 1